| Name | Cvs Pharmacy #16419 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 7845 N Macarthur Blvd, Irving, Texas 75063 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (972) 869-0474 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
Now on Kaiser Health News' blog, Ankita Rao reports: "While policymakers debate whether doctors should be paid by the number of services they provide or the outcomes of their treatment, shared decision could have an impact on the ground by reducing demand for medical procedures.
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Researchers at the University of Washington School of Medicine have found that bone marrow stem cells do not convert into heart muscle cells in mice. These results contradict a study conducted elsewhere that had prompted human clinical trials for such stem cell therapy in the treatment of heart attack.
Hospitals could sign on to an agreement with Senate health reform leader Max Baucus, D-Mont., and the White House to help save up to $200 billion as part of the overhaul plan, lobbyist and health industry sources tell Roll Call.
› Verified 4 days ago
| NPI Number | 1083636732 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY #16419 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 7845 N Macarthur Blvd, Irving, TX 75063 |
| Phone Number | 972-869-0474 |
News Archive
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
Now on Kaiser Health News' blog, Ankita Rao reports: "While policymakers debate whether doctors should be paid by the number of services they provide or the outcomes of their treatment, shared decision could have an impact on the ground by reducing demand for medical procedures.
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Researchers at the University of Washington School of Medicine have found that bone marrow stem cells do not convert into heart muscle cells in mice. These results contradict a study conducted elsewhere that had prompted human clinical trials for such stem cell therapy in the treatment of heart attack.
Hospitals could sign on to an agreement with Senate health reform leader Max Baucus, D-Mont., and the White House to help save up to $200 billion as part of the overhaul plan, lobbyist and health industry sources tell Roll Call.
› Verified 4 days ago
News Archive
Nanotherapeutics, Inc., today announced that it has been awarded a $30.9 Million, 5-year contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exposure prophylaxis and treatment of the Category A bioterrorism agent smallpox (Variola major).
Now on Kaiser Health News' blog, Ankita Rao reports: "While policymakers debate whether doctors should be paid by the number of services they provide or the outcomes of their treatment, shared decision could have an impact on the ground by reducing demand for medical procedures.
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Researchers at the University of Washington School of Medicine have found that bone marrow stem cells do not convert into heart muscle cells in mice. These results contradict a study conducted elsewhere that had prompted human clinical trials for such stem cell therapy in the treatment of heart attack.
Hospitals could sign on to an agreement with Senate health reform leader Max Baucus, D-Mont., and the White House to help save up to $200 billion as part of the overhaul plan, lobbyist and health industry sources tell Roll Call.
› Verified 4 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4343 W Royal Ln, Irving, Texas 75063 Phone: (972) 929-6800 | |
Advanced Arm Dynamics Of Texas, Llc Type: Medicare Supplier Location: 3501 N Macarthur Blvd, Irving, Texas 75062 Phone: (214) 260-3197 | |
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8300 Esters Blvd, Irving, Texas 75063 Phone: (972) 621-2005 | |
Amerita Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8080 Tristar Dr, Irving, Texas 75063 Phone: (972) 815-0460 | |
Cvs Pharmacy # 00015 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5500 N Macarthur Blvd, Irving, Texas 75038 Phone: (972) 518-1325 |